MAIA Biotechnology: Funding, Investors & Team (Oct 2026)
MAIA Biotechnology is a company that focuses on developing and selling targeted therapy and immune-oncology drugs with unique mechanisms of action to improve the lives of cancer patients. Based in Chicago and listed on the NYSE American, MAIA is led by a dedicated management team with extensive drug development experience, dedicated to advancing promising agents to clinical trials. MAIA's business strategy is aimed at creating value for its portfolio of potentially groundbreaking compounds. By diversifying its assets with different compounds that have novel mechanisms of action and potential activity in various types of tumors, MAIA mitigates risks and increases its chances of success. In MAIA's business model, each drug candidate is placed in its own specialized subsidiary company that focuses on research and development. This arrangement allows MAIA to provide focused support to each candidate while sharing resources and management capabilities across subsidiary companies, maintaining an efficient and cost-effective operating structure.
MAIA Biotechnology has raised $60.6M across 11 funding rounds on record, the most recent an undisclosed round of $30.0M announced in Mar 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MAIA Biotechnology Company Profile and Key Stats
Latest funding round on record: Mar 2026.
MAIA Biotechnology Funding Rounds
MAIA Biotechnology raised $4.0M in an undisclosed round announced in Nov 2023.
4 months later, an undisclosed round of $2.9M was announced in Mar 2024.
7 months later, an undisclosed round of $2.4M was announced in Oct 2024.
2 months later, an undisclosed round of $950k was announced in Dec 2024.
2 months later, an undisclosed round of $2.7M was announced in Feb 2025.
3 months later, an undisclosed round of $700k was announced in May 2025.
7 months later, an undisclosed round of $1.5M was announced in Dec 2025.
3 months later, an undisclosed round of $30.0M was announced in Mar 2026.
MAIA Biotechnology Founders and Leadership Team
Contact details for the MAIA Biotechnology team: 1 of 1 has an email address on file.
Start 14-day free trial →MAIA Biotechnology Funding Compared to Other Biotechnology Startups
MAIA Biotechnology's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MAIA Biotechnology in Biotechnology and Chicago
Companies Similar to MAIA Biotechnology
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
MAIA Biotechnology Funding FAQs
What does MAIA Biotechnology do?
MAIA Biotechnology is a company that focuses on developing and selling targeted therapy and immune-oncology drugs with unique mechanisms of action to improve the lives of cancer patients. Based in Chicago and listed on the NYSE American, MAIA is led by a dedicated management team with extensive drug development experience, dedicated to advancing promising agents to clinical trials. MAIA's business strategy is aimed at creating value for its portfolio of potentially groundbreaking compounds. By diversifying its assets with different compounds that have novel mechanisms of action and potential activity in various types of tumors, MAIA mitigates risks and increases its chances of success. In MAIA's business model, each drug candidate is placed in its own specialized subsidiary company that focuses on research and development. This arrangement allows MAIA to provide focused support to each candidate while sharing resources and management capabilities across subsidiary companies, maintaining an efficient and cost-effective operating structure.
How much funding has MAIA Biotechnology raised?
MAIA Biotechnology has raised $60.6M across 11 rounds on record. The most recent is an undisclosed round of $30.0M announced in Mar 2026.
When did MAIA Biotechnology last raise funding?
MAIA Biotechnology's most recent funding round on record is an undisclosed round of $30.0M, announced in Mar 2026.
Who founded MAIA Biotechnology?
FundedIQ lists Vlad Vitoc (Founder) at MAIA Biotechnology.
Where is MAIA Biotechnology headquartered?
MAIA Biotechnology is based in Chicago, Illinois, United States.
How many employees does MAIA Biotechnology have?
MAIA Biotechnology is in the 11-50 employee band.
How does MAIA Biotechnology's funding compare to other Biotechnology startups?
MAIA Biotechnology's latest round of $30.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's MAIA Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MAIA Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.